Glenn Matthew Chertow
Member of Medical Advisory BoardDr. Glenn Matthew Chertow, M. D. MPH, is Medical Advisor of Physiowave, Inc Dr. Chertow is Member of Scientific Advisory Board of Panoramic Health since March 2024. Dr. Chertow is a Professor of Epidemiology and Population Health and Professor of Health Policy at Stanford University School of Medicine. Dr. Chertow has served in leadership roles for multiple NIDDK-, NHLBI-, VA- and industry-sponsored clinical trials. He has served in multiple leadership roles with the American Society of Nephrology (ASN). Dr. Chertow was honored the Belding H. Scribner Award from ASN. Dr. Chertow serves as Chief of Division of Nephrology at Stanford University School of Medicine. He has been Medical Advisor and Member of Advisory Board at PuraCath Medical, Inc. Dr. Chertow served as Member of Scientific Advisory Board at Ardelyx Inc. since November 2020 until October 2023 and was Advisor. He serves as Member of Scientific Advisory Board at Unicycive Therapeutics, Inc. He practices nephrology at the Medical Specialties Clinic at Stanford. Dr. Chertow serves as a Member of Clinical Advisory Board of Cricket Health Inc. He serves as Member of Medical Advisory Board at SeaStar Medical Holding Corporation (formerly known as SeaStar Medical, Inc.). He was a Member of Kidney Scientific Advisory Board at DiaMedica Therapeutics Inc since May 2019. He serves as a Member of Scientific Advisory Board of Eliaz Therapeutics, Inc. and also serves as Director of Clinical Research since February 2022. He serves as a Member of Scientific Advisory Board at DaVita Clinical Research. He serves as Director and Member of Scientific Advisory Board of Satellite Healthcare, Inc. and served as its Trustee. He is Professor of Medicine at Stanford University School of Medicine. In 2008, he was appointed as the inaugural holder of the Norman S. Coplon/Satellite HealthCare Professorship of Medicine. He has been a referring physician for Satellite since 1999 and has strongly supported Satellite's mission to make life better for those living with kidney disease. He serves as Member of the American Society of Clinical Investigation, Association of American Professors and National Academy of Medicine. He has served as Associate Editor for the Journal American Society Nephrology (JASN) and is currently Co-Editor of Brenner and Rector?s The Kidney. Throughout years of experience in nephrology, Dr. Chertow has published over 200 articles and received numerous honors and awards. Dr. Chertow was honored by the American Kidney Fund in 2007 with the National Torchbearer Award and in 2011 with the Nephrologist of the Year Award. In 2018, Dr. Chertow received the David M. Hume Memorial Award from the National Kidney Foundation. Dr. Chertow holds BA from University of Pennsylvania (1985) and his MD from Harvard Medical School (1989) and MPH in Epidemiology and Biostatistics from Harvard School of Public Health from (1995) degrees at Harvard. He completed residency in internal medicine and fellowship in nephrology at Brigham and Women?s Hospital before joining the Harvard faculty, where he remained until 1998.
Positions
- Company NameSeaStar Medical Holding CorporationStock CodeICUPositionMember of Medical Advisory BoardRelated SecuritiesColleagues
- ESEric SchlorffCEO, Treasurer, President & Executive Director
- JAJennifer A. BairdIndependent Chairman of the Board
- MMMichael MessingerChief Financial Officer
- KCKevin ChungChief Medical Officer
- HDH. David HumesCo-Founder & Scientific Advisor
- TMTom MullenVice President of Operations & Product Development
- JNJohn NeumanIndependent Director
- RLRavindra L. MehtaMember of Medical Advisory Board
